LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| SK-BR-3 | Brivanib | 0.1634 |
| SK-BR-3 | CP466722 | 0.0472 |
| SK-BR-3 | AZD7762 | 1.2165 |
| SK-BR-3 | BMS345541 | 0.3900 |
| SK-BR-3 | Canertinib | 1.0665 |
| SK-BR-3 | CHIR-99021 | 0.2680 |
| SK-BR-3 | Afatinib | 1.1205 |
| SK-BR-3 | AZD-6482 | 0.2743 |
| SK-BR-3 | Barasertib | 1.0762 |
| SK-BR-3 | SNS-032 | 1.2444 |
| SK-BR-3 | BX-912 | 0.7706 |
| SK-BR-3 | Alpelisib | 0.4442 |
| SK-BR-3 | Celastrol | 0.8600 |
| SK-BR-3 | CGP60474 | 1.1468 |
| SK-BR-3 | Seliciclib | 0.1709 |
| SK-BR-3 | A443654 | 1.2708 |
| SK-BR-3 | AT-7519 | 1.1234 |
| SK-BR-3 | AZD 5438 | 0.8629 |
| SK-BR-3 | AZD8055 | 1.1417 |
| SK-BR-3 | AZD8330 | 0.2909 |
| SK-BR-3 | Dactolisib | 1.0156 |
| SK-BR-3 | BI-2536 | 1.1731 |
| SK-BR-3 | Buparlisib | 0.8877 |
| SK-BR-3 | Crizotinib | 0.4335 |
| SK-BR-3 | CP724714 | 0.8140 |